Yandex.Metrica

Stem Cell Therapy for Diabetes

Stem Cell Therapy for Diabetes

OVERVIEW

Name: Ahmed Saad Alghamdi
Diagnosis: Type-2 Diabetes (also peripheral vascular disease; primary hypertension)
D.O.B: 01 января 1955
Gender: Male
Country: Saudi Arabia

Treatment: Stem Cell Treatment; medications to enhance peripheral circulation; neuronal nutritional supplementation.

History

Patient Alghamdi Ahmed Saad, a 59 year-old male, was diagnosed locally as type-2 diabetes some 15 years before the current admission. At that time he presented with symptoms of polydipsia and polyuria. During initial efforts to treat with oral anti-diabetic medication, the patient’s blood sugar level was not effectively controlled, and his other diabetic symptoms worsened progressively. He had been treated with insulin for the ensuing 5 years, though control has been unstable.
 

Medical condition before Stem Cell Treatment

Prior to admission at Beijing Puhua International Hospital, the patient not only suffered from abiding fatigue, but also from joint pain in his limbs, and “gloved” feelings in his fingers and toes. The patient has a history of poor dietary control of his diabetes. He could sleep, but was also troubled with frequent urination. The initial physical examination in Beijing Puhua International Hospital revealed diminished sensitivity in patient’s peripheral nerves. According to the patient’s blood sugar record, the readings were around 10mmol/l in the morning on an empty stomach and around 12mmol/L before meals. Unfortunately, his blood sugar was very labile, and fluctuated widely, sometimes even shooting up over 28mmol/l.
 

Stem Cell Treatment

The patient was treated with 3 rounds of Stem Cell Treatment, combined with improvement of systemic circulation and nutritional supplementation of the nerve cells.
 

Medical condition after Stem Cell Treatment

After the first 2 rounds of Stem Cell Treatment, the record showed significantly lower blood sugar levels under patient’s usual oral medication of Glimepiride 6mg a day. Since the blood sugar level dropped down to 4mmol/l after the Stem Cell Treatments, the patient’s physician was able to reduce the Glimepiride dosage down to 3mg per day. Further, the Glargine (Lantus) insulin dosage was reduced from 20u to 18u per day. Since then, the patient’s blood sugar has been maintained at a fairly normal level (with the help of a much reduced medical regimen).It is possible that he even be able may stop using Glimepiride completely in the near future according to his physician, as well as continuing to lower his insulin dosage over the follow-up visits.
By the time the patient was discharged fromBeijing Puhua International Hospital, he was very enthusiastic over the results of his Stem Cell Treatment, the hospital and the staff. Mr. Saad left the hospital in much better control of his diabetes, and with the prospect of ongoing improvement in the weeks ahead.

 

Joomla SEO by AceSEF